G1 Therapeutics, Inc.
USD7.16
+0.01 (+0.14%)
CEO
John E. Bailey Jr.
IPO Date
2017-05-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.15
Prev. Close
$7.15
Day Low
$7.14
Day High
$7.16
52W Low
$1.08
52W High
$7.19
Market Cap
$0.38B
Volume
1.10M
| $2.99 |
| 18 Sept 2024 | MUIR GLENN P | director | U-Tender | Disposed | 185,358 | $0.00 |
| 18 Sept 2024 | MUIR GLENN P | director | D-Return | Disposed | 30,000 | $2.83 |
| 18 Sept 2024 | MUIR GLENN P | director | D-Return | Disposed | 30,000 | $5.30 |
| 18 Sept 2024 | MUIR GLENN P | director | D-Return | Disposed | 50,000 | $0.30 |
| 18 Sept 2024 | Avagliano Mark | Chief Business Officer | A-Award | Acquired | 20,600 | $0.00 |
| 18 Sept 2024 | Avagliano Mark | Chief Business Officer | D-Return | Disposed | 236,610 | $7.15 |
| 18 Sept 2024 | Avagliano Mark | Chief Business Officer | U-Tender | Disposed | 26,035 | $0.00 |
| 18 Sept 2024 | Avagliano Mark | Chief Business Officer | D-Return | Disposed | 89,400 | $2.97 |